CUREVAC
Live / Registered — Registered (as of 13 Apr 2021)
What this means for you
Registered since 13 Apr 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88602178
- Registration number
- 6318156
- Mark type
- Design + words
- Filed
- 03 Sept 2019
- Published for opposition
- 26 Jan 2021
- Registered
- 13 Apr 2021
- Attorney of record
- Jennifer Fraser
Goods and services
- Class 001 — Chemicals: Chemical reagents and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
- Class 005 — Pharmaceuticals: Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and cancer diseases, of tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements; Peptide carrier molecules for association with a biological macromolecule, for medical use, namely, for use in facilitating delivery of a wide range of medicinal substances; Peptidic carrier molecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic macromolecule or prophylactic biological marcomolecule; Peptide carrier molecule, sold in combination with a biological macromolecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic drug or prophylactic drug
- Class 042 — Scientific and technological services: Scientific and technological services and research, in particular scientific research for identification, testing and characterisation of biological macromolecules; medical testing services, namely, pre-clinical and clinical testing of macromolecules; scientific research in the nature of discovery of biological macromolecules; Laboratory services, related to custom manufacturing of pharmaceutical ingredients, for identification, testing and characterisation of biological macromolecules
- Class 044 — Medical, beauty and agricultural services: Medical and veterinary services, in particular for therapeutic and prophylactic treatment of cancer diseases, infectious diseases, autoimmune diseases or allergies; Medical and veterinary services for treating of hereditary disorders; Medical and veterinary services for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases and for treatment of endocrinological or metabolic disorders
Owner
- CUREVAC SE, TÜBINGEN, DE
- CureVac AG, Tübingen, DE
- CureVac AG, Tübingen, DE
- CureVac AG, Tübingen, DE
Prosecution history
- 08 Mar 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Sept 2021 — CORRECTION UNDER SECTION 7 - PROCESSED
- 30 Sept 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Apr 2021 — TEAS SECTION 7 REQUEST RECEIVED
- 13 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 26 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Jan 2021 — PUBLISHED FOR OPPOSITION
- 06 Jan 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Dec 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Dec 2020 — EXAMINER'S AMENDMENT ENTERED
- 17 Dec 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Dec 2020 — EXAMINERS AMENDMENT E-MAILED
- 17 Dec 2020 — EXAMINERS AMENDMENT -WRITTEN
- 16 Dec 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Dec 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE